QI
ANAB icon

QS Investors’s AnaptysBio ANAB Stock Holding History

QS Investors’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$387K Hold
14,900
– – ﹤0.01% 842
2021
Q1 		$322K Hold
14,900
– – ﹤0.01% 961
2020
Q4 		$320K Buy
+14,900
New +$362K ﹤0.01% 964
2020
Q3 		– Sell
-500
Closed -$12K – 1194
2020
Q2 		$12K Hold
500
– – ﹤0.01% 1521
2020
Q1 		$8K Buy
+500
New +$7.58K ﹤0.01% 1537

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

QS Investors's ANAB Position: Q2 2021 in Review

QS Investors held its AnaptysBio (ANAB) position steady in Q2 2021 at 14,900 shares worth $387K. The position accounts for ﹤0.01% of the portfolio, ranked #842.

QS Investors first reported a position in ANAB in Q1 2020 and has held it in 5 quarters since. 122 funds tracked by Wall St. Rank hold ANAB as of Q2 2021.

  • QS Investors held 14,900 shares of AnaptysBio worth $387K as of Q2 2021.
  • QS Investors left its AnaptysBio share count unchanged in Q2 2021.
  • AnaptysBio made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #842 holding.
  • QS Investors first reported a position in AnaptysBio in Q1 2020 and has held it in 5 quarters since.
  • 122 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.